Work

Open-label extension study of the RNAi therapeutic ALN-VSP02 in cancer patients responding to therapy.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.3062

Authors: Maria Alsina, Josep Tabernero, Geoffrey Shapiro, Howard Burris, Jeffrey R. Infante, Glen J. Weiss, Andres Cervantes-Ruiperez, Mrinal M. Gounder, Luis Paz-Ares, Rick Falzone, Jamie Hill, Jeffrey Cehelsky, Akshay Vaishnaw, Jared Gollob, Patricia LoRusso

Institutions: Vall d'Hebron Hospital Universitari, Dana-Farber Cancer Institute, Sarah Cannon, Universitat de València, INCLIVA Health Research Institute, Memorial Sloan Kettering Cancer Center, Hospital Universitario Virgen del Rocío, Alnylam Pharmaceuticals (United States), The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: RNA Interference and Gene Delivery

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3011400485

Cites:

Cited by: 10

Related to: 10